You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
Acute & Interventional Cardiology 2003; Volume 10: pages AIC 1- AIC 88
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 63–AIC 65
How can we establish the workforce required to deliver NSF targets for CHD? Experience in the North West of England
The ability to deliver increased cardiac services in line with the National Service Framework (NSF) is dependent on a skilled workforce being developed at an...
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 66–AIC 70
Isn’t it time for primary angioplasty in the UK?
Thrombolytic therapy remains the predominant reperfusion strategy for ST segment elevation myocardial infarction (STEMI) in the UK, with government policy directed towards optimising thrombolytic delivery....
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 75–AIC 77
The use of glycoprotein IIb/IIIa antagonists in acute coronary syndromes: are we following the NICE guidelines?
Recent developments in the management of non-ST elevation acute coronary syndromes (ACS) have included the introduction of glycoprotein (GP) IIb/IIIa inhibitors. The National Institute for...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 78–AIC 81
Implantable left ventricular assist devices
End-stage heart failure represents a major public health challenge and carries a poor prognosis. After a 30-year gestation period, mechanical assist devices are now poised...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 82–AIC 88
Atrial fibrillation after coronary bypass surgery – pathophysiology, resource utilisation and management strategies
Background: With an incidence rate of 30–50%, atrial fibrillation (AF) after bypass surgery continues to be one of the most common complications. The possibilities of...
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 37–AIC 40
Why do we need the CARDia trial?
The Coronary Artery Revascularisation in Diabetes (CARDia) trial is an investigator-initiated study and is the first prospective study designed specifically to address the hypothesis that...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 45–AIC 48
The frequency of acute coronary syndromes and the cost of glycoprotein IIb/IIIa inhibitor treatment
The objective of this survey was to estimate the proportion of episodes of acute coronary syndromes (ACS) without ST segment elevation in relation to the...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 49–AIC 51
Pre-operative strategies on clopidogrel use in coronary artery bypass grafting
There is a lack of standards pertaining to stopping antiplatelet agents in patients with acute coronary syndromes prior to coronary surgery. We conducted a national...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 52–AIC 55
Robotic coronary artery surgery
Cardiopulmonary bypass and the median sternotomy incision have revolutionised cardiac surgery, helping coronary artery bypass to become a routine procedure. Cardiopulmonary bypass was originally developed...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 56–AIC 58
Outcome of percutaneous coronary intervention in acute coronary syndromes: from clinical trials to clinical practice
Early angiography and revascularisation are beneficial for patients with non-ST segment elevation myocardial infarction (NSTEMI). However, the Prospective Registry of Acute Ischaemic Syndromes in the...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 59–AIC 60
Amnesia: a matter of the heart
Infective endocarditis can be difficult to diagnose, especially in the absence of typical clinical features or Duke criteria. Seeding of emboli to the cerebral cortex...
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 3–AIC 5
The donor crisis in heart transplantation
The donor crisis in heart transplantation John Pepper n the area of heart failure, public debate and research funding have been focused on new trends...
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 6–AIC 7
Future direction for the care of the acutely ill medical patient in the UK?
With the publication recently of the results of learned deliberations of two working parties of the Royal College of Physicians (RCP),1,2 attention continues to focus...
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 9–AIC 11
Heart attack patients in England are getting faster treatment but there is still more to do
The first public report on how the NHS manages acute
myocardial infarction (MI) in English hospitals was published on
19th November 2002.1 The report, based...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 17–AIC 20
The role of glucose-insulin-potassium therapy in the current management of acute myocardial infarction
Glucose-insulin-potassium (GIK) therapy addresses the metabolic changes of ischaemia secondary to acute myocardial infarction. These changes include elevated plasma free fatty acid concentration and glucose...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 22–AIC 27
Percutaneous intervention in unprotected left main coronary disease
A significant left main coronary artery (LMCA) stenosis is an important predictor of survival in patients with coronary artery disease. In the past, percutaneous coronary...
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 28–AIC 32
‘Real world’ small vessel coronary artery stenting: an analysis
The objective of this study was to describe the context, procedural outcome and long-term results of contemporary small vessel (SV) coronary artery stenting. It was...